Broderick Brian C Baxter International Inc Transaction History

Broderick Brian C

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$74.57 - $87.19 $268,452 - $313,884	-3,600 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$73.77 - $83.61 $7,377 - $8,361	-100 Reduced 2.7%	3,600 $290,000
Q2 2021 Aug 09, 2021	SELL	$80.5 - $88.01 $8,050 - $8,801	-100 Reduced 2.63%	3,700 $298,000
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $15,276 - $17,206	-200 Reduced 5.0%	3,800 $320,000
Q2 2020 Jul 28, 2020	SELL	$78.66 - $94.14 $15,732 - $18,828	-200 Reduced 4.76%	4,000 $344,000
Q1 2020 May 07, 2020	SELL	$71.57 - $93.3 $15,244 - $19,872	-213 Reduced 4.83%	4,200 $341,000
Q2 2019 Jul 24, 2019	SELL	$73.44 - $82.41 $7,344 - $8,241	-100 Reduced 2.22%	4,413 $361,000
Q1 2019 Apr 29, 2019	SELL	$64.48 - $81.31 $8,060 - $10,163	-125 Reduced 2.7%	4,513 $367,000
Q3 2018 Oct 15, 2018	SELL	$70.71 - $77.75 $56,567 - $62,200	-800 Reduced 14.71%	4,638 $358,000
Q3 2017 Oct 26, 2017	BUY	$59.5 - $64.61 $323,561 - $351,349	5,438	5,438 $341,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

Stay updated on Broderick Brian C with notifications on news.